Penn Medicine Healthy Heart
Launched by UNIVERSITY OF PENNSYLVANIA · Sep 25, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Penn Medicine Healthy Heart trial is a study aimed at helping patients in West and Southwest Philadelphia and Lancaster improve their blood pressure and cholesterol levels. The trial will use tools and platforms to identify patients who might benefit from a program designed to encourage healthier behaviors over a period of six months. This is important because high blood pressure and cholesterol can lead to serious health issues, and the study hopes to find effective ways to support patients in managing these conditions.
To participate, you need to be a patient in the Penn Medicine Primary Care network and have had high blood pressure readings (140 or higher) in the last year, along with certain risk factors for heart disease or diabetes. You also need to be off certain cholesterol medications or on a low-intensity statin with high cholesterol levels. If you’re selected, you can expect support and guidance to help you make positive changes to your health. It’s worth noting that the study is currently recruiting participants, so if you or someone you know fits the criteria, this could be a great opportunity to improve heart health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • On the Penn Medicine Primary Care Service Line registry
- • Last 2 Blood Pressure readings with Systolic Blood Pressure \>=140 from any outpatient encounter in the last 12 months AND
- • ASCVD dx OR ASCVD risk score ≥10% OR Diabetes dx OR A1c ≥6.5 in last year OR Diabetes registry OR Last LDL ≥190 in past five years AND
- • Not on a statinor PCSK9, Inclisiran OR on a Low-intensity/moderate-intensity statin) with LDL \>100
- Exclusion Criteria:
- • Patients on PCSK9 inhibitors
- • Documented statin allergy/ or intolerance in the EMR
- • Pregnancy
- • Breast feeding
- * Markedly shortened life expectancy including:
- • 1. metastatic cancer
- • 2. hospice
- • 3. End Stage Renal Disease
- • 4. Congestive Heart Failure
- • 5. Dementia
- • Is a non-English speaker requiring a translator
- • Patients who do not have a cell phone
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Kevin Volpp, MD, PhD
Principal Investigator
University of Pennsylvania
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported